Diana Lüftner
Beiersdorf (Germany)(DE)Koenig & Bauer (Germany)(DE)Catholic University Our Lady of Good Counsel(AL)Medizinische Hochschule Brandenburg Theodor Fontane(DE)Immanuel Krankenhaus(DE)Klinikum Brandenburg(DE)
Publications by Year
Research Areas
Advanced Breast Cancer Therapies, Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Comparison of Orally Administered Cannabis Extract and Delta-9-Tetrahydrocannabinol in Treating Patients With Cancer-Related Anorexia-Cachexia Syndrome: A Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Clinical Trial From the Cannabis-In-Cachexia-Study-Group(2006)408 cited
- → Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies(2005)153 cited
- → AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2021(2021)108 cited
- → Biomarkers in Patients with Metastatic Breast Cancer and the PRAEGNANT Study Network(2015)97 cited
- → Serum HER‐2/neu and relative resistance to trastuzumab‐based therapy in patients with metastatic breast cancer(2008)95 cited
- → Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) – Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Breast Cancer